Villafranca di Verona, Italy

Chiara Padroni

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chiara Padroni: Innovator in Neurodegenerative and Inflammatory Disease Treatments

Introduction

Chiara Padroni is a prominent inventor based in Villafranca di Verona, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurodegenerative disorders and inflammatory diseases. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Chiara Padroni holds a patent for "Inhibitors of complement factors and uses thereof." This patent discloses compounds of formula I and II, along with their pharmaceutically acceptable salts. The patent also outlines methods for treating various conditions, including neurodegenerative disorders, inflammatory diseases, autoimmune diseases, ophthalmic diseases, and metabolic disorders using the disclosed compounds. She has 1 patent to her name.

Career Highlights

Throughout her career, Chiara has worked with notable companies in the pharmaceutical industry. She has been associated with Annexon, Inc. and Aptuit (Verona) Srl, where she has contributed her expertise in drug development and research. Her work has been instrumental in advancing therapeutic options for patients suffering from complex diseases.

Collaborations

Chiara Padroni has collaborated with esteemed colleagues, including Dean R. Artis and Colin P. Leslie. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of medical advancements.

Conclusion

Chiara Padroni is a remarkable inventor whose work in the pharmaceutical field has the potential to impact the treatment of various diseases significantly. Her dedication to innovation and collaboration continues to drive her success in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…